Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -13.04% and 12.76%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock ...

Back in 2017, he was the lone “no” vote on a popular anti-human trafficking bill. Years later, he was the subject of a sex ...

Medically reviewed by Mary Choy, PharmD Amlodipine is a commonly prescribed calcium channel blocker medication used to treat ...